Rhythm Pharmaceuticals (NASDAQ: RYTM) on Thursday posted upbeat results for the fourth quarter. The company posted a quarterly loss of 73 cents per share, versus market estimates of a loss of 81 cents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results